drugset / Trial / NCT00451750

Cortisol in the Treatment of Phobias

NCT00451750

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.

Timeline

Start
2007-05
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 20 mg

Indications